| 000 | 01785 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513112404.0 | ||
| 264 | 0 | _c19970506 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a1044-9523 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohansson, N | |
| 245 | 0 | 0 |
_aCollagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. _h[electronic resource] |
| 260 |
_bCell growth & differentiation : the molecular biology journal of the American Association for Cancer Research _cFeb 1997 |
||
| 300 |
_a243-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Line, Transformed _xdrug effects |
| 650 | 0 | 4 |
_aCollagenases _xbiosynthesis |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
| 650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMatrix Metalloproteinase 13 |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xdrug effects |
| 650 | 0 | 4 |
_aTretinoin _xpharmacology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xdrug effects |
| 700 | 1 | _aWestermarck, J | |
| 700 | 1 | _aLeppä, S | |
| 700 | 1 | _aHäkkinen, L | |
| 700 | 1 | _aKoivisto, L | |
| 700 | 1 | _aLópez-Otín, C | |
| 700 | 1 | _aPeltonen, J | |
| 700 | 1 | _aHeino, J | |
| 700 | 1 | _aKähäri, V M | |
| 773 | 0 |
_tCell growth & differentiation : the molecular biology journal of the American Association for Cancer Research _gvol. 8 _gno. 2 _gp. 243-50 |
|
| 999 |
_c9029575 _d9029575 |
||